Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution. (17th March 2021)

Record Type:: Journal Article
Title:: Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution. (17th March 2021)
Main Title:: Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution
Authors:: Kok, Yonatan
Nicolopoulos, Jenny
Dolianitis, Con
Abstract:
Is Part Of:: Australasian journal of dermatology. Volume 62:Number 2(2021)
Journal:: Australasian journal of dermatology
Issue:: Volume 62:Number 2(2021)
Issue Display:: Volume 62, Issue 2 (2021)
Year:: 2021
Volume:: 62
Issue:: 2
Issue Sort Value:: 2021-0062-0002-0000
Page Start:: e313
Page End:: e316
Publication Date:: 2021-03-17
Subjects:: Dermatology -- Periodicals
Dermatology -- Australasia -- Periodicals
616.5005
Journal URLs:: http://www.blackwell-synergy.com/loi/ajd ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/ajd.13559 ↗
Languages:: English
ISSNs:: 0004-8380
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1794.900000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16812.xml